|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-4-7
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Dipeptidyl peptidase-4 inhibitors act by increasing plasma levels of glucagon-like peptide-1 and suppressing excessive glucagon secretion in patients with type 2 diabetes. However, their effects on the glucagon response to hypoglycemia are not established.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adamantane,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Glucagon,
http://linkedlifedata.com/resource/pubmed/chemical/Glucagon-Like Peptide 1,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Nitriles,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrrolidines,
http://linkedlifedata.com/resource/pubmed/chemical/vildagliptin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1945-7197
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
94
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1236-43
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19174497-Adamantane,
pubmed-meshheading:19174497-Aged,
pubmed-meshheading:19174497-Blood Glucose,
pubmed-meshheading:19174497-Body Mass Index,
pubmed-meshheading:19174497-Cross-Over Studies,
pubmed-meshheading:19174497-Diabetes Mellitus, Type 2,
pubmed-meshheading:19174497-Double-Blind Method,
pubmed-meshheading:19174497-Female,
pubmed-meshheading:19174497-Glucagon,
pubmed-meshheading:19174497-Glucagon-Like Peptide 1,
pubmed-meshheading:19174497-Hemoglobin A, Glycosylated,
pubmed-meshheading:19174497-Humans,
pubmed-meshheading:19174497-Hyperglycemia,
pubmed-meshheading:19174497-Hypoglycemia,
pubmed-meshheading:19174497-Hypoglycemic Agents,
pubmed-meshheading:19174497-Insulin,
pubmed-meshheading:19174497-Male,
pubmed-meshheading:19174497-Middle Aged,
pubmed-meshheading:19174497-Nitriles,
pubmed-meshheading:19174497-Pyrrolidines
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes.
|
|
pubmed:affiliation |
Department of Clinical Sciences, Lund University, Lund, Sweden. bo.ahren@med.lu.se
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
